The Semaglutide and Exenatide Market is experiencing remarkable growth due to the increasing global prevalence of type 2 diabetes and obesity, coupled with the growing adoption of glucagon-like peptide-1 (GLP-1) receptor agonists. Semaglutide and exenatide have become important therapeutic options because they effectively improve glycemic control, promote weight loss, and reduce cardiovascular...